Literature DB >> 3215272

Evidence for an A2 adenosine receptor in human coronary arteries.

M V Ramagopal1, R W Chitwood, S J Mustafa.   

Abstract

The present study was an attempt to characterize the type of adenosine receptor in human coronary arteries obtained from organ donors with the use of adenosine analogs. Prostaglandin F2 alpha (10(-6) M) produced tonic contractions followed by phasic contractions and diltiazem (10(-6) M) pretreatment changed the phasic contractions to tonic contractions. Adenosine and its analogs (5'-N-ethyl-carboxamide adenosine, NECA and N6-L-phenyl-isopropyl adenosine, L-PIA), produced concentration-dependent relaxations of the tonic contractions and the order of potency was found to be: NECA greater than L-PIA greater than adenosine. 8-Phenyltheophylline (5 X 10(-6) M) antagonized the relaxations produced by adenosine and its analogs. The data suggest the existence of A2 adenosine receptor in human coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3215272     DOI: 10.1016/0014-2999(88)90548-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  Adenosine mediates relaxation of human small resistance-like coronary arteries via A2B receptors.

Authors:  B K Kemp; T M Cocks
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Role of ω-hydroxylase in adenosine-mediated aortic response through MAP kinase using A2A-receptor knockout mice.

Authors:  Dovenia S Ponnoth; Mohammed A Nayeem; Swati S Kunduri; Stephen L Tilley; Darryl C Zeldin; Catherine Ledent; S Jamal Mustafa
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

3.  Drug Delivery and Nanoformulations for the Cardiovascular System.

Authors:  W J Geldenhuys; M T Khayat; J Yun; M A Nayeem
Journal:  Res Rev Drug Deliv       Date:  2017-03-07

Review 4.  Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology.

Authors:  S Jamal Mustafa; R Ray Morrison; Bunyen Teng; Amir Pelleg
Journal:  Handb Exp Pharmacol       Date:  2009

Review 5.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

6.  Characterization of the adenosine receptor in porcine coronary arteries.

Authors:  A D King; M Milavec-Krizman; E Müller-Schweinitzer
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

7.  Evidence that A2 purinoceptors are involved in endothelium-dependent relaxation of the rat thoracic aorta.

Authors:  R B Rose'Meyer; W Hope
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

8.  Effects of P1 and P2Y purinoceptor antagonists on endothelium-dependent and -independent relaxations of rat mesenteric artery to GTP and guanosine.

Authors:  P Vuorinen; X Wu; P Arvola; H Vapaatalo; I Pörsti
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

9.  ATL 313, A Selective A(2A) Adenosine Receptor Agonist, Reduces Myocardial Infarct Size in a Rat Ischemia/Reperfusion Model.

Authors:  Wangde Dai; Sharon L Hale; Rohith Nayak; Robert A Kloner
Journal:  Open Cardiovasc Med J       Date:  2009-11-25

10.  Relaxation by adenosine and its analogs of potassium-contracted human coronary arteries.

Authors:  M H Sabouni; M V Ramagopal; S J Mustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.